Connect with us

National

First human trial of Oxford COVID-19 vaccine shows promise – Reuters

An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.

Published

on

post featured image

LONDON (Reuters) – An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The vaccine, called AZD1222, has been described by the World Health Organization’s chief scientist as the leading candidate in a global race to halt a pandemic that has killed more than 600,000 people.
More than 150 possible vacc…

Click here to view the original article.